GSK PLC

{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 44874.24, 47155.2, 48596.74, 50754.87, 49609.32 ], "ebit_estimate": [ 13210.39, 14391.88, 14553.76, 15140.98, 14864.99 ], "ebitda_estimate": [ 15275.98, 16642.74, 17026.34, 17155.73, 17507.82 ], "net_income_estimate": [ 9327.51, 10262.57, 10686.4, 11179.69, 11082.24 ], "per_share_eps_estimate": [ 2.67, 2.9, 2.49, 2.7, null ], "eps_nri_estimate": [ 4.6, 4.96, 4.45, 3.84, 5.04 ], "dividend_estimate": [ 1.66, 1.72, 1.71, 1.58, 2.24 ], "book_value_per_share_estimate": [ 12.85, 15.29, 17.71, 20.33, 23.21 ], "pretax_income_estimate": [ 12068.42, 13302.71, 14049.87, 14572.68, 14344.67 ], "operating_cash_flow_per_share_estimate": [ 4.87, 5.4, 5.84, 6.15, 6.46 ], "roa_estimate": [ 10.6, 9.9, 9.7, 9.5, 9.4 ], "roe_estimate": [ 36.27, 30.95, 27.23, 22.7, 20.7 ], "gross_margin_estimate": [ 75.35, 75.55, 75.38, 75, 75 ], "operating_cash_flow_estimate": [ 9918.15, 10991.65, 11892.01, 12525.51, 13163.09 ], "pettm_estimate": [ 19.75, 18.22, 21.22, 19.58, null ], "long_term_growth_rate_mean": 5.87, "long_term_revenue_growth_rate_mean": "4.04", "future_per_share_eps_estimate_growth": 9.5, "future_eps_nri_estimate_growth": 5.87, "future_revenue_estimate_growth": 4.04, "future_ebit_estimate_growth": 4.48, "future_ebitda_estimate_growth": 4.3, "future_dividend_estimate_growth": 6.11, "future_net_income_estimate_growth": 5.65, "future_pretax_income_estimate_growth": 10.86, "future_book_value_per_share_estimate_growth": 13.15, "future_roa_estimate_growth": -2.26, "future_roe_estimate_growth": -11.79, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": 9.52 }

{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ 10909.98, 11817.73, 11820.8, 10467.1, 11205.79, 12109.38, 12181.93 ], "ebit_estimate": [ 3465.53, 3947.14, 2361.83, 3652.6, 3632.81, 4289.73, 2435.07 ], "ebitda_estimate": [ 4092.35, 4307.47, 3028.63, null, null, null, null ], "net_income_estimate": [ 2507.09, 2794.22, 1497.73, 2501.02, 2477.28, 3026.03, 1468.16 ], "per_share_eps_estimate": [ 1.01, 1.09, 0.48, null, null, null, null ], "eps_nri_estimate": [ 1.24, 1.43, 0.87, null, null, null, null ], "dividend_estimate": [ null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null ], "pretax_income_estimate": [ 3279.51, 3769.98, 1968.5, 3327.24, 3313.98, 3980.75, 2124.92 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null ], "gross_margin_estimate": [ 75.5, 76.3, 72.1, 77.5, 75.8, 76.6, 72.4 ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null ], "pettm_estimate": [ null, null, null, null, null, null, null ], "long_term_growth_rate_mean": 5.87, "long_term_revenue_growth_rate_mean": "4.04", "future_per_share_eps_estimate_growth": 9.5, "future_eps_nri_estimate_growth": 5.87, "future_revenue_estimate_growth": 4.04, "future_ebit_estimate_growth": 4.48, "future_ebitda_estimate_growth": 4.3, "future_dividend_estimate_growth": 6.11, "future_net_income_estimate_growth": 5.65, "future_pretax_income_estimate_growth": 10.86, "future_book_value_per_share_estimate_growth": 13.15, "future_roa_estimate_growth": -2.26, "future_roe_estimate_growth": -11.79, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": 9.52 }